At2g04300 Antibody

What is the At2g04300 antibody and what does it detect?

At2g04300 antibody is a polyclonal antibody raised in rabbits that specifically recognizes the Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 protein in Arabidopsis thaliana. This protein belongs to the leucine-rich repeat protein kinase family and is encoded by the At2g04300 gene, also referred to as T23O15.8 or T23O15_8 in the Arabidopsis genome. The antibody targets epitopes specific to this protein, which functions as a receptor-like kinase with potential roles in signal transduction pathways in plant cells. The protein contains characteristic leucine-rich repeat domains that facilitate protein-protein interactions and a serine/threonine kinase domain (EC 2.7.11.1) involved in phosphorylation activities. Researchers primarily use this antibody to study receptor kinase expression, localization, and function in plant developmental processes and stress responses .

What are the validated applications for At2g04300 antibody?

The At2g04300 antibody has been validated for multiple research applications with varying optimization requirements. The primary validated applications include Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB), which have been confirmed to reliably detect the target protein when proper experimental conditions are maintained. In Western Blot applications, the antibody enables detection of the target protein after separation by SDS-PAGE and subsequent transfer to a membrane, providing information about protein expression levels and molecular weight. For ELISA applications, the antibody facilitates quantitative detection of the target protein in solution-phase samples, allowing for more precise measurement of protein concentrations across different experimental conditions. While not explicitly validated, researchers have explored using this antibody for immunoprecipitation experiments to isolate protein complexes associated with At2g04300, though these applications may require additional optimization and validation by individual laboratories. All applications benefit from the antibody's antigen-affinity purification, which increases specificity and reduces background interference .

How does At2g04300 protein function in Arabidopsis thaliana?

At2g04300 protein functions as a leucine-rich repeat receptor-like serine/threonine protein kinase in Arabidopsis thaliana, participating in signal transduction pathways critical for plant development and environmental responses. The protein's structure features an extracellular domain containing leucine-rich repeats (LRRs) that recognize and bind specific ligands, a transmembrane domain that anchors the protein to the cell membrane, and an intracellular kinase domain that catalyzes phosphorylation reactions. Upon ligand binding, the receptor likely undergoes conformational changes that activate its kinase domain, initiating downstream signaling cascades through phosphorylation of target proteins. Similar to other LRR receptor-like kinases in plants, At2g04300 may participate in various biological processes including pathogen recognition, hormone signaling, cell differentiation, or stress responses. Unlike some closely related proteins that have been extensively characterized (such as BRASSINOSTEROID INSENSITIVE 1), the precise biological functions and specific ligands for At2g04300 remain areas of active investigation, making antibodies against this protein particularly valuable for elucidating its roles in plant biology .

How should I design a Western blot experiment using At2g04300 antibody?

When designing a Western blot experiment using At2g04300 antibody, researchers should consider several critical parameters to ensure optimal results. Begin by carefully extracting total protein from Arabidopsis thaliana tissues using a buffer containing protease inhibitors to prevent degradation of the target protein, which is particularly important for membrane-associated receptor-like kinases. Include appropriate positive controls (recombinant At2g04300 protein if available) and negative controls (protein extracts from knockout plants lacking At2g04300 expression) to validate specificity. Regarding protein separation, use 8-10% SDS-PAGE gels to achieve optimal resolution around the expected molecular weight of At2g04300 (approximately 100-120 kDa). After transfer to a nitrocellulose or PVDF membrane, block with 5% non-fat dry milk or BSA in TBST for at least 1 hour to minimize non-specific binding. For primary antibody incubation, dilute the At2g04300 antibody at a range of 1:500 to 1:2000 in blocking solution and incubate overnight at 4°C for optimal binding to the target protein. After washing, use an appropriate HRP-conjugated anti-rabbit secondary antibody (typically at 1:5000 to 1:10000 dilution) followed by chemiluminescent detection. Due to potential variability in expression levels across different tissues or developmental stages, initial optimization of antibody dilutions and protein loading amounts may be necessary to achieve the desired signal-to-noise ratio .

What are the best sample preparation methods for detecting At2g04300 protein?

For optimal detection of At2g04300 protein, sample preparation methods must effectively preserve protein integrity while maximizing extraction efficiency of this membrane-associated receptor-like kinase. Begin by flash-freezing freshly harvested Arabidopsis tissues in liquid nitrogen and grinding to a fine powder using a cold mortar and pestle to prevent protein degradation. Extract total proteins using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100 (or 0.5-1% NP-40), 0.1% SDS, 5 mM EDTA, supplemented with freshly added 1 mM DTT, 1 mM PMSF, and a commercial protease inhibitor cocktail. The inclusion of detergents is crucial for solubilizing membrane-bound proteins like At2g04300, while protease inhibitors prevent degradation during extraction. For phosphorylation studies, add phosphatase inhibitors such as 5 mM sodium fluoride and 1 mM sodium orthovanadate to the extraction buffer. After homogenization, incubate samples on ice for 30 minutes with occasional vortexing, followed by centrifugation at 12,000-15,000g for 15 minutes at 4°C to remove cellular debris. Carefully collect the supernatant containing solubilized proteins and determine protein concentration using Bradford or BCA assay. For membrane protein enrichment, consider ultracentrifugation at 100,000g to isolate membrane fractions prior to immunodetection. Store protein extracts in small aliquots at -80°C to avoid freeze-thaw cycles that could compromise protein integrity .

How can I determine the appropriate antibody dilution for my experiments?

Determining the optimal antibody dilution for At2g04300 antibody requires a systematic titration approach to balance specific signal intensity against background noise across different applications. For Western blot applications, prepare a dilution series of the antibody (typically ranging from 1:250 to 1:5000) while maintaining consistent sample loading, blocking, and detection conditions. Evaluate signal-to-noise ratio at each dilution, seeking the highest dilution that provides clear, specific detection of the target band at the expected molecular weight without excessive background. For ELISA applications, perform a similar titration series using known positive and negative control samples, testing primary antibody dilutions from 1:100 to 1:10,000 to generate a response curve and identify the dilution providing the highest signal difference between positive and negative controls. Consider that optimal dilution may vary depending on the tissue type, protein expression level, and detection method employed. When working with samples where At2g04300 expression may be low, such as certain tissue types or under specific experimental conditions, lower dilutions (1:250 to 1:500) may be necessary, while samples with higher expression levels may permit higher dilutions (1:2000 to 1:5000). Document the optimization process comprehensively, including the specific detection method, incubation times and temperatures, and wash conditions to ensure reproducibility in future experiments .

What controls should be included when using At2g04300 antibody?

When working with At2g04300 antibody, incorporating a comprehensive set of controls is essential for validating experimental results and distinguishing specific signal from artifacts. Include a positive control consisting of recombinant At2g04300 protein or protein extract from tissues known to express the target protein at detectable levels, which provides confirmation of antibody functionality and appropriate detection conditions. A negative control should incorporate protein extracts from At2g04300 knockout or knockdown plant lines, allowing clear distinction between specific binding and non-specific interactions. Include a loading control (such as anti-actin or anti-tubulin antibody detection) to normalize target protein levels across samples and ensure equal protein loading. For evaluating antibody specificity, perform a pre-absorption control by pre-incubating the antibody with excess purified antigen before application to samples, which should significantly reduce or eliminate specific signal if the antibody is truly target-specific. An isotype control using non-specific rabbit IgG at the same concentration as the primary antibody helps distinguish non-specific binding attributed to the antibody class. For phosphorylation studies, include samples treated with phosphatase to demonstrate specificity if using phospho-specific antibodies against At2g04300. This comprehensive control strategy enables confident interpretation of experimental results and facilitates troubleshooting when unexpected patterns emerge .

How can I use At2g04300 antibody to study protein-protein interactions?

To investigate protein-protein interactions involving At2g04300, researchers can employ co-immunoprecipitation (co-IP) techniques optimized for plant membrane-associated receptor-like kinases. Begin by extracting proteins under non-denaturing conditions using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5-1% NP-40 or a milder detergent like digitonin (0.5-1%), supplemented with protease and phosphatase inhibitors to preserve native protein structures and interaction interfaces. Pre-clear the lysate by incubating with Protein A/G beads for 1 hour at 4°C to remove proteins that bind non-specifically to the beads. Incubate the pre-cleared lysate with At2g04300 antibody (typically 2-5 μg per 1 mg of total protein) overnight at 4°C with gentle rotation, followed by addition of fresh Protein A/G beads for 2-4 hours to capture antibody-protein complexes. After thorough washing with buffer containing progressively lower detergent concentrations (starting at 0.1% and reducing to 0.05%), elute bound proteins for analysis by SDS-PAGE and either Western blotting with antibodies against suspected interaction partners or mass spectrometry for unbiased identification of co-precipitated proteins. For crosslinking-assisted co-IP, treat intact tissues or cells with membrane-permeable crosslinkers like DSP (dithiobis[succinimidylpropionate]) at 1-2 mM for 30 minutes before extraction to stabilize transient interactions. Validate identified interactions using reverse co-IP (using antibodies against the interaction partner to pull down At2g04300) and consider complementary approaches such as split-YFP, FRET, or yeast two-hybrid assays for comprehensive confirmation .

How can I investigate At2g04300 localization at the subcellular level?

Investigating the subcellular localization of At2g04300 protein requires techniques that preserve cellular architecture while enabling specific detection of this receptor-like kinase. Immunofluorescence microscopy represents a direct approach: fix Arabidopsis tissues or cultured cells using 4% paraformaldehyde, permeabilize with 0.1-0.5% Triton X-100, block with 3-5% BSA or normal serum, and incubate with At2g04300 antibody (typically at 1:100 to 1:500 dilution) followed by fluorophore-conjugated secondary antibody detection. Counter-stain with markers for cellular compartments (e.g., plasma membrane: FM4-64; endoplasmic reticulum: ER-Tracker; Golgi: anti-SEC21) to precisely define localization patterns. For higher resolution, employ confocal microscopy to visualize co-localization with organelle markers through optical sectioning. Perform subcellular fractionation as a complementary biochemical approach: separate cellular components using differential centrifugation to isolate plasma membrane, cytosolic, nuclear, and organellar fractions, then analyze each fraction by Western blotting with At2g04300 antibody alongside fraction-specific marker proteins. For dynamic localization studies, consider establishing transgenic Arabidopsis lines expressing fluorescently-tagged At2g04300 under native promoter control, allowing live-cell imaging to track protein movement in response to developmental cues or environmental stimuli. Super-resolution microscopy techniques such as STORM or PALM can provide nanometer-scale resolution of At2g04300 distribution patterns when combined with appropriate fluorophore-conjugated secondary antibodies, revealing potential clustering or association with specific membrane microdomains that might be functionally significant .

What approaches can resolve contradictory results when using At2g04300 antibody?

When faced with contradictory results using At2g04300 antibody, implement a systematic troubleshooting strategy addressing multiple variables that could affect antibody performance and experimental outcomes. First, validate antibody specificity using genetic controls: compare detection patterns between wild-type Arabidopsis and confirmed At2g04300 knockout mutants, which should demonstrate absence of specific signal in the mutant. Test antibody recognition capability using recombinant At2g04300 protein in Western blot experiments across a concentration gradient to establish detection limits and confirm binding to the intended target. Evaluate epitope accessibility by comparing different protein extraction methods, as the leucine-rich repeat and transmembrane domains of At2g04300 may require specific detergent conditions for proper solubilization and epitope exposure. Consider potential post-translational modifications or protein processing events that might affect antibody recognition by treating samples with phosphatases, glycosidases, or other enzymes prior to analysis. For inconsistent results between laboratories, standardize experimental protocols including tissue harvest conditions, protein extraction methods, blocking reagents, and detection systems. If contradictions persist, sequence the immunogen used to generate the antibody and compare with the current reference sequence for At2g04300 to identify potential sequence variations or polymorphisms. Consider obtaining a different At2g04300 antibody that recognizes a distinct epitope for comparative analysis, or generate epitope-tagged versions of At2g04300 in transgenic plants that can be detected with highly specific commercial tag antibodies as an alternative approach .

How should ELISA protocols be optimized for At2g04300 detection?

Optimizing ELISA protocols for At2g04300 detection requires methodical refinement of multiple parameters to achieve maximum sensitivity and specificity. Begin by selecting the appropriate ELISA format: indirect ELISA for qualitative detection or sandwich ELISA for quantitative measurement using a capture antibody against At2g04300 and the detection antibody against another epitope or a tag. For coating conditions, evaluate different concentrations of capture antibody (typically ranging from 1-10 μg/ml) in coating buffer (carbonate-bicarbonate buffer, pH 9.6) and incubation times (overnight at 4°C versus 2-4 hours at room temperature) to determine optimal antigen capture efficiency. Systematically test different blocking agents (BSA, non-fat dry milk, commercial blocking buffers) at various concentrations (1-5%) to minimize background while preserving specific signal. Optimize sample preparation by comparing different extraction buffers and dilution series to identify conditions that maximize target protein availability while minimizing matrix effects. For detection, titrate primary antibody concentrations (typically from 1:500 to 1:5000) and secondary antibody dilutions (typically from 1:1000 to 1:10000) to achieve the optimal signal-to-noise ratio. Consider the detection system carefully: HRP-conjugated secondary antibodies with TMB substrate provide good sensitivity for colorimetric detection, while chemiluminescent substrates offer enhanced sensitivity for low-abundance targets like many plant receptor kinases. The table below summarizes key optimization parameters:

For each parameter, test multiple conditions while holding others constant to determine the optimal combination for At2g04300 detection .

What strategies improve Western blot sensitivity for detecting low-abundance At2g04300?

Enhancing Western blot sensitivity for detecting low-abundance At2g04300 protein requires implementation of multiple optimization strategies targeting each step of the protocol. Begin with sample preparation optimization: enrich for membrane proteins through ultracentrifugation or two-phase partitioning systems, as receptor-like kinases like At2g04300 typically localize to membranes and may be diluted in whole-cell extracts. For protein loading, increase sample concentration (up to 50-80 μg per lane) while maintaining good resolution, and consider using gradient gels (4-15%) to improve separation and concentration of target proteins. Optimize transfer efficiency by selecting PVDF membranes (which typically offer higher protein binding capacity than nitrocellulose) and implementing a sequential transfer protocol with decreasing buffer methanol concentration (20% to 10%) to improve transfer of membrane proteins. For antibody incubation, extend primary antibody incubation time to overnight at 4°C and test lower dilutions (1:250 to 1:500) to maximize binding opportunities for the antibody. Enhance signal amplification by employing high-sensitivity chemiluminescent substrates (e.g., SuperSignal West Femto or similar) or consider biotin-streptavidin amplification systems that can provide 2-4 fold signal enhancement. Implement enhanced imaging protocols using longer exposure times with cooled CCD cameras to capture weak signals while minimizing background. For further sensitivity enhancement, consider tyramide signal amplification (TSA), which can provide up to 100-fold increase in detection sensitivity through HRP-catalyzed deposition of additional tyramide-conjugated fluorophores or HRP molecules at the site of primary detection. As a last resort, perform immunoprecipitation to concentrate At2g04300 protein prior to Western blot analysis, effectively increasing the amount of target protein relative to total protein background .

How can I minimize cross-reactivity when using At2g04300 antibody?

Minimizing cross-reactivity when using At2g04300 antibody requires implementation of strategies that enhance binding specificity while reducing non-specific interactions. Begin by optimizing blocking conditions: test different blocking agents including BSA (1-5%), non-fat dry milk (1-5%), commercial blocking buffers, or casein (0.5-2%), as certain blocking agents may better prevent non-specific binding to particular sample types. Implement stringent washing procedures using TBS-T or PBS-T with varied Tween-20 concentrations (0.05-0.1%) and increased washing durations (5-10 minutes per wash) repeated 4-6 times between antibody incubations. Consider adding low concentrations of detergents (0.1-0.2% Triton X-100) or salt (up to 500 mM NaCl) to antibody dilution buffers to disrupt low-affinity, non-specific interactions while preserving high-affinity binding to the specific target. For Western blotting, cut membranes strategically to separately probe regions containing the target protein versus regions where cross-reactive bands appear, allowing different optimization conditions for each region. Implement antibody pre-adsorption by incubating the diluted antibody with proteins from Arabidopsis at2g04300 knockout tissues to remove antibodies that bind to proteins other than the target. For particularly challenging cross-reactivity issues, consider immunoaffinity purification of the polyclonal antibody using recombinant At2g04300 protein coupled to a solid support to isolate only those antibody molecules with high specificity for the target. The table below presents a systematic approach to troubleshooting cross-reactivity:

Through systematic implementation of these approaches, researchers can significantly reduce cross-reactivity while maintaining specific detection of At2g04300 .

How does At2g04300 compare to other leucine-rich repeat receptor-like kinases?

At2g04300 belongs to the extensive leucine-rich repeat receptor-like kinase (LRR-RLK) family in Arabidopsis thaliana, which comprises over 200 members with diverse functions in plant development and stress responses. Structurally, At2g04300 shares the characteristic domain organization of LRR-RLKs, featuring extracellular leucine-rich repeats, a transmembrane domain, and an intracellular serine/threonine kinase domain similar to well-characterized family members like BRASSINOSTEROID INSENSITIVE 1 (BRI1) and FLAGELLIN SENSING 2 (FLS2). Phylogenetic analysis places At2g04300 within subfamily XI of LRR-RLKs, which includes several members involved in developmental processes and cell fate determination rather than immunity-related functions predominant in subfamily XII. Unlike more extensively studied LRR-RLKs such as BRI1, FLS2, or CLAVATA1, At2g04300 has fewer documented interaction partners and its specific ligand remains unidentified, representing a knowledge gap in receptor-ligand biology. The kinase domain of At2g04300 contains conserved catalytic residues suggestive of active kinase function, contrasting with approximately 20% of Arabidopsis receptor kinases classified as pseudokinases lacking catalytic activity. Expression pattern analysis reveals that At2g04300 exhibits tissue-specific expression predominantly in developing tissues, unlike more ubiquitously expressed LRR-RLKs involved in fundamental processes or pathogen sensing. When studying At2g04300, researchers should consider these comparative aspects to inform experimental design, particularly when selecting appropriate controls from related LRR-RLKs or when interpreting phenotypic effects of genetic manipulation .

What are the challenges in studying receptor-like kinases using antibody-based approaches?

Studying receptor-like kinases (RLKs) like At2g04300 using antibody-based approaches presents several significant challenges requiring specialized techniques and careful experimental design. Membrane localization represents a primary obstacle, as RLKs are integral membrane proteins that require effective solubilization with appropriate detergents (Triton X-100, NP-40, or digitonin) to maintain protein structure while extracting from lipid environments. Low endogenous expression levels of many RLKs, often below detection limits of standard immunological methods, necessitate concentration steps, enrichment of membrane fractions, or signal amplification techniques to achieve reliable detection. Protein glycosylation and other post-translational modifications of the extracellular domains can mask epitopes or alter antibody recognition, requiring deglycosylation treatments (using enzymes like PNGase F) to improve detection in some cases. Cross-reactivity presents a substantial challenge due to the high sequence homology among the large RLK family in Arabidopsis (>600 members), demanding extensive validation using genetic knockout controls to confirm specificity. Antibody generation itself poses difficulties, as the transmembrane nature of RLKs complicates production of full-length recombinant proteins for immunization, often necessitating use of peptide fragments or domains that may not perfectly represent the native protein conformation. Dynamic regulation of RLKs through endocytosis, recycling, and degradation creates temporal and spatial variability in protein localization and abundance, requiring careful timing of experiments and potentially rapid sample processing to capture the protein in its biologically relevant state. Additionally, protein-protein interactions involving RLKs often depend on specific stimuli or conditions, making co-immunoprecipitation experiments particularly challenging when attempting to identify transient or condition-specific interaction partners .

How can At2g04300 antibody be used in combination with other molecular biology techniques?

At2g04300 antibody can be strategically combined with complementary molecular biology techniques to create powerful experimental workflows that yield comprehensive insights into protein function, regulation, and interactions. Integrate immunoprecipitation with mass spectrometry (IP-MS) by using At2g04300 antibody to pull down the target protein and its interaction partners, followed by tryptic digestion and LC-MS/MS analysis to identify the complete interactome, providing unbiased discovery of novel protein associations beyond targeted co-IP approaches. Combine chromatin immunoprecipitation (ChIP) with At2g04300 antibody in studies investigating potential nuclear translocation of the kinase domain following receptor activation, which has been documented for several plant receptor kinases with dual membrane/nuclear functions. Implement the antibody in proximity-dependent biotin identification (BioID) or APEX2 proximity labeling systems by creating fusion proteins with At2g04300 and biotin ligase, allowing antibody verification of expression while the proximity system captures the spatial environment of the protein. Enhance functional genomics approaches by using At2g04300 antibody to validate CRISPR/Cas9 gene editing outcomes at the protein level, confirming complete protein knockout or successful epitope tagging in modified plant lines. Strengthen metabolomic studies examining pathways potentially regulated by At2g04300 signaling by correlating metabolite changes with protein expression or phosphorylation levels detected by the antibody. For understanding tissue-specific expression patterns, combine in situ hybridization detecting At2g04300 mRNA with immunohistochemistry using the antibody to correlate transcriptional and translational regulation across development or stress responses. Implement the antibody in single-cell protein analysis workflows by using it for antibody-based cell sorting followed by single-cell sequencing, enabling correlation between At2g04300 protein expression and transcriptome profiles at the individual cell level .

What are the key considerations for successful experiments with At2g04300 antibody?

Successful implementation of At2g04300 antibody in research protocols requires careful attention to multiple critical factors that influence experimental outcomes and data reliability. Antibody validation represents the foundational consideration: researchers must verify specificity using genetic controls (preferably at2g04300 knockout lines) and recombinant protein standards before proceeding with experimental applications. Sample preparation methodology significantly impacts detection success, particularly for this membrane-localized receptor-like kinase—optimize extraction buffers with appropriate detergents (0.5-1% Triton X-100 or NP-40) and protective additives (protease/phosphatase inhibitors) to preserve protein integrity while effectively solubilizing membrane components. Experimental design must incorporate appropriate positive and negative controls, including loading controls for normalization and isotype controls to distinguish specific from non-specific binding. Protocol optimization represents an essential investment, as standard immunological protocols often require substantial modification for optimal detection of plant receptor kinases—systematically test variables including antibody dilutions, incubation times/temperatures, and detection systems to establish reliable protocols for each specific application. Documentation of optimization parameters, including lot-specific antibody information, is crucial for experimental reproducibility both within and between laboratories. Technical considerations such as storage conditions (aliquoted at -20°C or -80°C, avoiding freeze-thaw cycles) and handling practices (maintaining cold chain, minimizing exposure to strong detergents post-dilution) significantly impact antibody performance over time. Finally, data interpretation must account for the biological context of At2g04300, including tissue-specific expression patterns, developmental regulation, and potential post-translational modifications that might influence detection patterns across experimental conditions .